What is not working for the company?
What is working for the company?
|Name||Dec 22||Sep 22|
|Mutual Funds (Change:0.00)||0%||0%|
|Insurance Companies (Change:0.00)||0%||0%|
|Other DIIs (Change:0.00)||0.08%||0.08%|
|Non Institution (Change:-0.00)||53.1%||53.1%|
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in BIOFIL CHEMICALS & PHARMACEUTICALS LTD.
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
Frequently Asked Questions
What is the Share price of BIOFIL CHEMICALS & PHARMACEUTICALS LTD. (BIOFILCHEM)?
Can I buy BIOFIL CHEMICALS & PHARMACEUTICALS LTD. (BIOFILCHEM) shares?
How do I buy BIOFIL CHEMICALS & PHARMACEUTICALS LTD. (BIOFILCHEM) from Angel One?
- Direct investment: You can buy BIOFIL CHEMICALS & PHARMACEUTICALS LTD. (BIOFILCHEM) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to BIOFIL CHEMICALS & PHARMACEUTICALS LTD. (BIOFILCHEM) shares.
In which sector do BIOFIL CHEMICALS & PHARMACEUTICALS LTD. (BIOFILCHEM) belong?
Today's live share price for BIOFIL CHEMICALS & PHARMACEUTICALS LTD. is NSE: ₹ 48.95, BSE: ₹ 49.15 with a current market capitalization of .
Biofil Chemicals & Pharmaceuticals (BCPL) was incorporated as a private limited company on 4 Jan.'85 for manufacture of pharmaceutical products and it was converted into a public limited company on 7 May '92. It was promoted by the Systematix group and Ramesh Shah of the Cyano group. Ramesh Shah is the chairman and managing director and Anand Kumar Sethiya is the managing director. In Feb.'96, the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively, both aggregating Rs 23.21 cr, to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations. The company currently manufactures pharmaceutical formulations like injections, capsules, eye-drops and dry syrups at its plant located in Indore. BCPL's new unit is being set up at Pithampur in Madhya Pradesh at a project cost of Rs 39.75 cr and will manufacture bulk drugs like astemizole, cefaclor, pentazocine, cefazolin sodium and cefotoxime sodium. It is also setting up a R&D centre which will include a pilot plant for bulk drugs and separate sections for formulations development and will house modern analytical instruments. During the year 1999-2000, the company had achieved a turnover of Rs.1164.03 lakhs.Read more